THE European Union will bar Chinese companies from participating in eu public tenders for medical devices worth EUR60 billion (US$68.9 billion) or more per year after concluding that EU companies are not given fair access in China, reports Reuters.
The measure announced by the European Commission is the first under the EU's International Procurement Instrument, which entered into force in 2022 and is designed to ensure reciprocal market access.
The new restrictions are likely to increase tensions with Beijing inflamed by EU tariffs on China-built electric vehicles, Chinese measures against EU brandy and curbs on exports of rare earths that the EU wants resolved by an EU-China summit in July.
The Commission said that it would exclude Chinese companies from EU government purchases above EUR5 million.
SeaNews Turkey
The measure announced by the European Commission is the first under the EU's International Procurement Instrument, which entered into force in 2022 and is designed to ensure reciprocal market access.
The new restrictions are likely to increase tensions with Beijing inflamed by EU tariffs on China-built electric vehicles, Chinese measures against EU brandy and curbs on exports of rare earths that the EU wants resolved by an EU-China summit in July.
The Commission said that it would exclude Chinese companies from EU government purchases above EUR5 million.
SeaNews Turkey
